Patients with CKD display a significantly higher risk of cardiovascular and thromboembolic
complications, with around half of patients with advanced CKD ultimately dying of …

Because of its high prevalence, chronic kidney disease (CKD) remains a major health
hazard throughout the world. Patients with CKD have a high prevalence and incidence of …

Aims The aim of the present study was to establish the safety and efficacy profile of
prasugrel and ticagrelor in real-life acute coronary syndrome (ACS) patients with renal …

Atrial fibrillation (AF) and chronic kidney disease (CKD) are strictly related; several
independent risk factors of AF are often frequent in CKD patients. AF prevalence is very …

Background There are limited data on how the combination of diabetes mellitus (DM) and
chronic kidney disease (CKD) affects cardiovascular outcomes as well as response to …

Background We sought to determine temporal trends in use of evidence‐based therapies
and clinical outcomes among myocardial infarction (MI) patients with chronic kidney disease …

With population ageing and rise of life expectancy, a progressively increasing proportion of
patients presenting with an acute coronary syndrome (ACS) are older adults, including those …

Chronic kidney disease patients are at increased risk of cardiovascular disease, which is the
leading cause of mortality among this population. In addition, chronic kidney disease is a …

Results This cohort included 6648 patients on clopidogrel, 621 on prasugrel, and 449 on
ticagrelor. A total of 3279 primary composite (cardiovascular death, myocardial infarction, or …

This study aims to evaluate potentially appropriate antiplatelet therapy in patients with
chronic kidney disease. A systematic analysis was conducted to identify the clinical …